- Ezekiel J.
Emanuel, David Wendler, Christine Grady, What Makes
Clinical Research Ethical?
- Ezekiel J. Emanuel, David Wendler, Jack Killen, Christine
Grady, What
Makes Clinical Research in Developing Countries Ethical: the Benchmarks of
Ethical Research
- NIH Cliniccal Center The Department of Bioethics, Clinical Ethics
and Ethics Consultation
- Nuffield Council on Bioethics, The
ethics of research related to healthcare in developing countries
- Bioethics Discussion Pages, For What
Reasons Would You as a Patient Enter a Randomized Clinical Drug Trial?
- National Bioethics Advisory Commission`s Reports (1997-2001)
- Andreas J. Reuland, Menschenversuche
in der Weimarer Republik
- Jing Jing Liu, Emma Davidson, Aziz Sheikh, Achieving
Ethnic Diversity in Trial Recruitment
- Allison R. Baer, Susan Devine, Chris David Beardmore, Robert
Catalano, Clinical
Investigator Responsibilities
- Frank Davidoff, Catherine D. DeAngelis, Jefferz M. Drazen,
M. Gary Nicholls, John Hoey,
- G. H.. Guyatt, L. B. Berman, M. Townsend, S. O. Pugsley, L.
W. Chambers, A measure of quality of
life for
clinical trials in chronic lung disease
- Harold
C. Sox, Seeding
trials: just say "no"
- Hiroaki Yanagawa, Masatoshi Kishuku, Masashi Akaike,
Hiroyuki Azuma, Minoru Irahara, View of physicians
on and barriers to patient enrollment in a multicenter clinical trial:
experience in a Japanese rural area
- R. Peto, M. C. Pike, P. Armitage, N. E. Breslow, D. R. Cox,
S. V. Howard, N. Mantel, K. McPherson, J. Peto, P. G. Smith, Design and analysis
of randomized clinical trials requiring prolonged observation of each patient.
I. Introduction and design
- R. Peto, M. C. Pike, P. Armitage, N. E. Breslow, D. R. Cox,
S. V. Howard, N. Mantel, K. McPherson, J. Peto, P. G. Smith, Design and analysis
of randomized clinical trials requiring prolonged observation of each patient.
II. analysis and examples
- Liselotte Højgaard, Richard Horton, Sheldon Kotzin,
Magne Nylenna, A. Overbeke, Harold C. Sox, Martin Weyden, Michael S. Wilkes, Sponsorship,
authorship and accountability
- James Paul, Rachael Seib, Todd Prescott, The Internet and Clinical Trials:
Background, Online Resources, Examples and Issues
- Keya Acharya, India: Prime
Destination for Unethical Clinical Trials
- Yamin Khan, Sarah Tilly, Seasonality: The
Clinical Trial Manager`s Logistical Challenge
- Jill A. Fisher, Corey A. Kalbaugh, United
States Private-Sector Physicians and Pharmaceutical Contract Research: A
Qualitative Study
- Paula A. Rochon, Melanie Sekeres, John Hoey, Joel Lexchin,
Lorraine E Ferris, David Moher, Wei Wu, Sunila R Kalkar, Marleen Van Laethem,
Andrea Gruneir, Jennifer Gold, James Maskalyk, David L Streiner, Nathan Taback,
An-Wen Chan, Investigator
experiences with financial conflicts of interest in clinical trials
- Barbara Kelly, Marilyn J. MacKay-Lyons, Ethics
of Involving Children in Health-Related Research: Applying a Decision-Making
Framework to a Clinical Trial
- L. Miller, M. Folayan, D. Allman, B. Nkala, L. M. Kasirye,
L. R. Mingote, G. Calazans, R. Mburu, F. Ntombela, M. Ditmore, How
ethical is your clinical trial?
- Dinko Vitezić, Maja Lovrek, Siniša Tomić, Centralized
National Ethical Review of Clinical Trials in Croatia
- Allison Baer, Naftali Bechar, Gary Cohen, Basic
Steps to Building a Research Program
- John D. Steeves, Jose Zariffa, John L.K. Kramer, Are
You "Tilting at Windmills" or Undertaking a Valid Clinical Trial?
- Jeremy Sugarman, Colleen Sitlani, Dug Andrusiek, Tom
Aufderheide, Eileen M. Bulger, Daniel P. Davis, David B. Hoyt, Ahamed Idris,
Jeffrey D. Kerby, Judy Powell, Terri Schmidt, Arthur S. Slutsky, George Sopko,
Shannon Stephens, Carolyn Williams, Graham Nichol, Is
the Enrollment of Racial
and Ethnic Minorities in Research in the Emergency Setting Equitable?
- Neema Sofaer, Carrie Thiessen, Susan Dorr Goold, Janice
Ballou, Kenneth A. Getz, Greg Koski, Richard A. Krueger, Joel S. Weissman, Subjects’
views of obligations to ensure post-trial access to drugs, care, and
information: Qualitative results from the Experiences of Participants in
Clinical Trials (EPIC) Study
- Patrick D. Lyden, Brett C. Meyer, Thomas M. Hemmen, Karen S.
Rapp, An
Ethical Hierarchy for Decision Making During Medical Emergencies
- Alice K. Fortune-Greeley, N. Chantelle Hardy, Li Lin, Joëlle
Y. Friedman, Janice S. Lawlor, Lawrence H. Muhlbaier, Mark A. Hall, Kevin A.
Schulman, Jeremy Sugarman, Kevin P. Weinfurt, Patients`
Reactions to Confidentiality, Liability, and Financial Aspects of Informed
Consent in Cardiology Research
- David B. Resnik, Frank Miller, The
Ethics of Sham Surgery on Research Subjects with Cognitivie Impairments that
Affect Decision-Making Capacity
- Liza Dawson, Deborah A. Zarin, Ezekiel J. Emanuel, Lawrence
M. Friedman, Bimal Chaudhari, Steven N. Goodman, Considering
Usual Medical Care in Clinical Trial Design
- Scott Y. H. Kim, Jason Karlawish, H. Myra Kim, Ian F. Wall,
Andrea Bozoki, Paul S. Appelbaum, Preservation
of the Capacity to Appoint a Proxy Decision Maker: Implications for Dementia Research
- Craig A. Umscheid, David J. Margolis, Craig E. Grossman, Key
Concepts of Clinical Trials: A Narrative Review
- Harriette G. C. Van
Spall, Andrew Toren, Alex Kiss, Robert A. Fowler, Eligibility
Criteria of Randomized Controlled Trials Published in High-Impact General
Medical Journals
- Allen C. Cheng, "Self-experimentation"
in vulnerable populations.
- Vera Hassner Sharav, Human Experiments:
A Chronology of Human Research
- Association of American Medical Colleges, Conflicts of Interest in Research
- Projekty badawcze i konferencje – Research projects and
conferences
- FDA
Clinical Trial Requirements Regulations, Compliance, and GCP Conference – “This two-day
conference is intended to share information among FDA representatives and the
regulated community, to facilitate the understanding of regulations, guidelines
and practices, and to suggest methods and opportunities to enhance the research
professional’s product development experience. The program will focus on the
relationships among the FDA and clinical trial staff, investigators and IRBs.
The workshop will highlight three areas that present challenges to sponsors and
investigational sites: FDA Clinical Research Requirements, Enhancing Success
through Communication and Financial Incentives, and Assuring Confidence in
Clinical Research.”
|